Paper1290920
A comparison of the effects of the selective peripheral alpha 1-blocker terazosin with the selective beta 1-blocker atenolol on blood pressure, exercise performance and the lipid profile in mild-to-moderate essential hypertension.
Ligueros M and 5 others. Clin Auton Res, 1992. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. A comparison of the effects of the selective peripheral alpha 1-blocker terazosin with the selective beta 1-blocker atenolol on blood pressure, exercise performance and the lipid profile in mild-to-moderate essential hypertension. Papers, record 1290920. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1290920
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
A comparison of the effects of the selective peripheral alpha 1-blocker terazosin with the selective beta 1-blocker atenolol on blood pressure, exercise performance and the lipid profile in mild-to-moderate essential hypertension.
- PubMed
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atenolol | Major topic |
| Blood Pressure | Major topic |
| Hypertension | Major topic |
| Physical Exertion | Major topic |
| Prazosin | Major topic |
| Adult | |
| Cholesterol | |
| Cholesterol, HDL | |
| Cholesterol, LDL | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Randomized Controlled Trials as Topic |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2572847 | Effects of exercise and fat ingestion on high density lipoprotein production by peripheral tissues. | Lancet | 1989 | https://conductscience.org/library/papers/2572847 | PubMed |
| 2 | 2564723 | The effects of terazosin and methyclothiazide on blood pressure and serum lipids. | Am Heart J | 1989 | https://conductscience.org/library/papers/2564723 | PubMed |
| 3 | 1824647 | Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism. | Am Heart J | 1991 | https://conductscience.org/library/papers/1824647 | PubMed |
| 4 | 3993543 | Exercise training during long-term beta-blockade treatment in healthy subjects. | Am J Cardiol | 1985 | https://conductscience.org/library/papers/3993543 | PubMed |
| 5 | 2884854 | Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension. | Am J Cardiol | 1987 | https://conductscience.org/library/papers/2884854 | PubMed |
| 6 | 552299 | The two-period cross-over clinical trial. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/552299 | PubMed |
| 7 | 2872813 | Effect of terazosin on serum lipids. | Am J Med | 1986 | https://conductscience.org/library/papers/2872813 | PubMed |
| 8 | 1851792 | Physical exercise in the management of hypertension: a consensus statement by the World Hypertension League. | J Hypertens | 1991 | https://conductscience.org/library/papers/1851792 | PubMed |
| 9 | 2872812 | Overall safety of terazosin as an antihypertensive agent. | Am J Med | 1986 | https://conductscience.org/library/papers/2872812 | PubMed |
| 10 | 3510088 | The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. | Circulation | 1986 | https://conductscience.org/library/papers/3510088 | PubMed |
| 11 | 2953239 | Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans. | Am J Med | 1987 | https://conductscience.org/library/papers/2953239 | PubMed |
| 12 | 6637786 | Metabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: lipid alterations and glucose intolerance. | Am Heart J | 1983 | https://conductscience.org/library/papers/6637786 | PubMed |
| 13 | 6734082 | Post-exercise reduction of blood pressure in hypertensive men is not due to acute impairment of baroreflex function. | Clin Sci (Lond) | 1984 | https://conductscience.org/library/papers/6734082 | PubMed |
| 14 | 6375340 | Effects of beta 1-selective and nonselective beta-adrenoceptor blockade during exercise conditioning in healthy adults. | Am J Cardiol | 1984 | https://conductscience.org/library/papers/6375340 | PubMed |
| 15 | 2885169 | Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension. | Drugs | 1987 | https://conductscience.org/library/papers/2885169 | PubMed |
| 16 | 3065104 | Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. | Diabetologia | 1988 | https://conductscience.org/library/papers/3065104 | PubMed |
| 17 | 6712861 | The effects of acute or chronic ingestion of propranolol or metoprolol on the physiological responses to prolonged, submaximal exercise in hypertensive men. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6712861 | PubMed |
| 18 | 6743386 | Effect of atenolol on plasma HDL cholesterol subfractions. | Atherosclerosis | 1984 | https://conductscience.org/library/papers/6743386 | PubMed |
| 19 | 2872806 | Comparative trials of terazosin with other antihypertensive agents. | Am J Med | 1986 | https://conductscience.org/library/papers/2872806 | PubMed |
| 20 | 2872809 | Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension. | Am J Med | 1986 | https://conductscience.org/library/papers/2872809 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADRB1 | 153 | PubTator's text mining | https://conductscience.org/library/genes/153 | NCBI Gene |
| BCL2A1 | 597 | PubTator's text mining | https://conductscience.org/library/genes/597 | NCBI Gene |
| MS4A1 | 931 | PubTator's text mining | https://conductscience.org/library/genes/931 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1290920
GET https://conductscience.org/api/papers/v1/1290920/references?page=2